Market News AIOpen the app

CRVS stock news · Corvus Pharmaceuticals

Stories about Corvus Pharmaceuticals (CRVS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CRVS

Follow Corvus Pharmaceuticals (CRVS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CRVS
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 5:18 PM ET · Market

    Corvus Pharma lost $20.3 million last quarter and spent $17.8 million on research.

    Neutral

    Corvus reported research costs of $17.8 million, up from $8.5 million, and a $20.3 million loss. Cash is expected to fund work into Q2 2028, so the update is mixed.